A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Determination of the Relative Bioavailability of ARQ 197 Tablet Formulation With Capsule C Formulation as a Reference in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
- Status
- COMPLETED
- Phase
- PHASE1
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007)
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005
- Status
- TERMINATED
- Phase
- PHASE1